Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
PROJECT SUMMARY
Biofilms are surface-attached microbial communities that pose a significant clinical problem, in part because
biofilm cells are highly antibiotic tolerant. Device-related biofilm infections incur costs of >1 billion dollars
annually. Moreover, lethal Pseudomonas aeruginosa biofilm infections are common in cystic fibrosis (CF) and
other respiratory diseases. A better understanding of how microbial communities form is required to prevent or
reverse biofilm formation. Our reported studies show that P. aeruginosa can detect surface contact via a
pathway requiring Type IV pili (TFP) and a membrane-bound signaling complex that generates the second
messenger cAMP. Our recent findings using cell tracking of entire communities at single-cell resolution and
combined with a cAMP reporter lead to our Central Hypothesis: Surface sensing is predicated on cAMP-TFP-
based memory, and does not occur by gradually increasing surface residence times of attached cells and their
intracellular cAMP. Rather, the surface induces phase-shifted temporal waves of intracellular cAMP levels and
TFP activity that constitute a `memory' of the surface. This memory, which is multigenerational and surprisingly
robust, allows planktonic descendants of surface-exposed cells to adapt to the surface and increase surface
cell populations orders of magnitude faster than their ancestors upon attachment. To understand this pivotal
event, we will use population-level and single-cell analyses, combined with molecular genetic approaches
within a rigorous biophysical theoretical framework, to explore the mechanistic underpinnings of these earliest
events in biofilm formation. We will (1) test the hypothesis that surface contact induces phase-shifted waves of
cAMP levels and TFP activity that encode a memory of the surface, allowing for surface adaptation that
drastically modifies behavior of cells on surfaces, (2) test the hypothesis that surface sensing is transmitted via
integrating TFP mechanical retraction, inner membrane dynamics of PilA, and the formation of an inner
membrane PilJ-PilA complex required for cAMP signaling. Upon completion of the proposed studies, we will
have established the mechanism by which P. aeruginosa senses and irreversibly attaches to a surface. Given
that irreversible attachment is the first committed step in biofilm formation, our work uncovers a key aspect of
bacterial biology.
Public Health Relevance Statement
PROJECT NARRATIVE
Biofilms are surface-attached microbial communities that pose a significant clinical problem, and biofilm
infections lead to hundreds of millions of dollars in healthcare costs annually. We aim to understand how these
microbial communities form so that we can prevent or reverse biofilm formation, and focus specifically on
Pseudomonas aeruginosa, which contributes to lethal infections in cystic fibrosis, ventilator-associated
pneumonia and burn wounds.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
092530369
UEI
RN64EPNH8JC6
Project Start Date
22-January-2019
Project End Date
31-December-2023
Budget Start Date
01-January-2021
Budget End Date
31-December-2021
Project Funding Information for 2021
Total Funding
$389,806
Direct Costs
$329,680
Indirect Costs
$60,126
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Allergy and Infectious Diseases
$389,806
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI143730-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI143730-03
Patents
No Patents information available for 5R01AI143730-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI143730-03
Clinical Studies
No Clinical Studies information available for 5R01AI143730-03
News and More
Related News Releases
No news release information available for 5R01AI143730-03
History
No Historical information available for 5R01AI143730-03
Similar Projects
No Similar Projects information available for 5R01AI143730-03